These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20274519)

  • 1. Comparison of pressor action of aliphatic amines.
    SWANSON EE; CHEN KK
    J Pharmacol Exp Ther; 1946 Sep; 88(1):10-3. PubMed ID: 20274519
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of pressor amines in the etiology of experimental and essential hypertension.
    HELMER OM; PEIRCE JD; SHIPLEY RE
    Proc Am Fed Clin Res; 1947; 3(1 Vol):22. PubMed ID: 18908365
    [No Abstract]   [Full Text] [Related]  

  • 3. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. III. The specific hypotensive action of some pressor amines.
    HUIDOBRO F; CROXATTO R
    Acta Physiol Lat Am; 1951 Dec; 1(4):277-90. PubMed ID: 14943556
    [No Abstract]   [Full Text] [Related]  

  • 4. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. II. Effects of dibenamine on the hypertensive action of pressor amines.
    HUIDOBRO F; CROXATTO R; MANOSALVA W
    Acta Physiol Lat Am; 1951 Jul; 1(3):187-99. PubMed ID: 14943549
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative pharmacological study of the inhibiting action of psychopharmacological agents on the effects of biological amines].
    Lorenzo Fernández P
    Arch Inst Farmacol Exp (Madr); 1965; 17(1):5-51. PubMed ID: 5893485
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of pressor action of alicyclic derivatives of aliphatic amines.
    SWANSON EE; CHEN KK
    J Pharmacol Exp Ther; 1948 Aug; 93(3):423-9. PubMed ID: 18878182
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic N-oxidation products of aliphatic amines as potential mediators in amine pharmacology.
    Gorrod JW; Jenner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):180-5. PubMed ID: 1172491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. I. Blockade of the hypertensive action of vasopressor amines by the effect of the same substances.
    HUIDOBRO F; CROXATTO R; ALLENDE J; DEL RIO J
    Acta Physiol Lat Am; 1951 Feb; 1(2):91-109. PubMed ID: 14943542
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of aminoxydase inhibition on the effects of biogenic amines].
    BALZER H; HOLTZ P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 227(6):547-58. PubMed ID: 13334562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phenylcyclohexylamines and derivatives. III. 3- and 4- phenylcyclohexylamines mono- and di-substituted with nitrogen. Their local anesthetic and pressor activity].
    Cantarelli G; Carissimi M; D'Ambrosio R; Gentili P; Grumelli E; Milla E; Panelli M; Ravenna F
    Farmaco Sci; 1970 Apr; 25(4):248-94. PubMed ID: 5427274
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyridinium analogs of the pressor amines; the benzene series.
    RIEGEL B; WITTCOFF H
    J Am Chem Soc; 1946 Sep; 68(9):1805. PubMed ID: 21001097
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of some biogenic amines on the blood pressure of pargyline-treated rabbits.
    Airaksinen MM; Mustala O; Torsti P
    Ann Med Exp Biol Fenn; 1966; 44(3):376-81. PubMed ID: 5958855
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiating and pressor action of some n-substituted hexylamines.
    LEWIS JR
    Fed Proc; 1946; 5(1 Pt 2):62. PubMed ID: 21066329
    [No Abstract]   [Full Text] [Related]  

  • 14. [Decrease of blood pressure by penhexamine and penbutamine verified by a bloodless rheoplethysmographic method].
    VANECEK M; TRCKA V
    Cesk Fysiol; 1959 Sep; 8():462-3. PubMed ID: 13841239
    [No Abstract]   [Full Text] [Related]  

  • 15. The cardiovascular pharmacology of t-butylamine.
    BAUM T; HORNBROOK KR; VASQUEZ-LEON H; BENNETT DR
    J Pharmacol Exp Ther; 1962 Sep; 137():275-84. PubMed ID: 13865906
    [No Abstract]   [Full Text] [Related]  

  • 16. Aliphatic versus aromatic amines as vasoconstrictors.
    CHEN KK
    Ann Otol Rhinol Laryngol; 1948 Jun; 57(2):287-97. PubMed ID: 18872514
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of some aliphatic amines on the frog flow device].
    HAUSCHILD F; LANDBECK H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1948; 205(2-3):203-9. PubMed ID: 18879992
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardio-vascular effects of two aliphatic amines and of ephedrine.
    WALTON RP; BRODIE OJ
    J Pharmacol Exp Ther; 1949 Aug; 96(4 Pt. 1):343-51. PubMed ID: 18137888
    [No Abstract]   [Full Text] [Related]  

  • 19. Pressor amines containing nuclear chlorine and fluorine.
    FOSDICK LS; FANCHER O; URBACH KF
    J Am Chem Soc; 1946 May; 68():840-3. PubMed ID: 21024888
    [No Abstract]   [Full Text] [Related]  

  • 20. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. V. Theoretical fundaments; drug receptor linkage.
    CROXATTO R; HUIDOBRO F
    Arch Int Pharmacodyn Ther; 1956 Apr; 106(1-2):207-43. PubMed ID: 13328228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.